Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshio Mukuta is active.

Publication


Featured researches published by Toshio Mukuta.


Eating and Weight Disorders-studies on Anorexia Bulimia and Obesity | 1998

Iodine-induced hypothyroidism as a result of excessive intake of confectionery made with tangle weed, Kombu, used as a low calorie food during a bulimic period in a patient with anorexia nervosa

Sunao Matsubayashi; Toshio Mukuta; H. Watanabe; H. Fuchigami; J. Taniguchi; M. Chinen; H. Ninomiya; H. Sasaki

A 20-year-old Japanese female anorectic patient developed primary hypothy roidism associated with generalized edema because of excessive daily intake (40 to 50 g) o confectionery made with tangle weed, Kombu, which she substituted to food during bulimic periods; TSH 60.35 mcU/ml, free T3 1.19 pg/ml, and free T4 0.48 ng/dl, and her weigh increased by 12 kg to 45 kg over 4 months. After withdrawal of Kombu her thyroid function returned to normal, and her weight decreased by 7 kg to 38 kg along with disappearance o edema. In conclusion, the physician noticed that susceptible anorectic patients may sometime develop hypothyroidism or hyperthyroidism because of excessive iodine intake of sea-weed confectionery as a substitute of high calorie cakes during bulimic period.


Clinical Endocrinology | 1992

The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post‐partum hypothyroidism

Takeshi Hara; Hajime Tamai; Toshio Mukuta; Shujl Fukatat; Kanji Kuma

objective We investigated the association between thyroid function and the biological activities of thyroid stimulating antibodies (TSAb) and thyroid stimulation blocking antibodies (TSBAb) in patients with post‐partum hypothyroidism.


British Journal of Nutrition | 1992

Alterations in endothelium-associated proteins and serum thyroid hormone concentrations in anorexia nervosa

Gen Komaki; Hajime Tamai; Toshio Mukuta; Nobuyuki Kobayashi; Kenji Mori; Tetsuya Nakagawa; Lindy F. Kumagai

Plasma concentrations of endothelium-associated proteins (EAP) (plasma fibronectin (PFN), angiotensin-converting enzyme, factor VIII-related antigen (F VIII-R:Ag)) and tissue plasminogen activator and serum thyroid hormone concentrations were studied in nine patients with anorexia nervosa (AN), before and after weight gain. Before weight gain (-35.9 (SE 2.3)% of standard body-weight) PFN was significantly reduced and F VIII-R:Ag was significantly increased in AN patients compared with the concentrations in control subjects (211.5 (SE 14.9) v. 274.7 (SE 16.6) micrograms/ml, P < 0.05; 129.2 (SE 14.1) v. 88.2 (SE 9.7) %, P < 0.05 respectively). Serum triiodothyronine (T3) and free T3 levels were also significantly lower before weight gain in AN patients (0.85 (SE 0.07) v. 1.53 (SE 0.08) nmol/l, P < 0.001; 2.57 (SE 0.23) v. 5.31 (SE 0.34) pmol/l, P < 0.001 respectively), although serum thyroxine (T4), free T4, and thyrotropin concentrations were within the normal range throughout the study periods. Following weight gain, PFN and F VIII-R:Ag concentrations normalized as did the thyroid hormone levels. The incremental changes in PFN levels correlated significantly with those in serum thyroid hormone concentrations (T3, r 0.79, P < 0.01; free T3, r 0.84, P < 0.01). These findings suggest that PFN levels may be directly related to serum T3 concentrations in AN patients.


Clinical Endocrinology | 1993

A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.

Takeshi Hara; Hajime Tamai; Toshio Mukuta; Shuji Fukata; Kanji Kuma; Tetsuya Nakagawa

OBJECTIVE Although non‐toxic diffuse goitre is a common disorder, little is known of the clinical course of patients. We therefore decided to investigate the long‐term clinical outcome of patients with non‐toxic diffuse goitre.


The Journal of Clinical Endocrinology and Metabolism | 1995

The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland

Sunao Matsubayashi; Keisuke Kawai; Yoshiaki Matsumoto; Toshio Mukuta; Tetsuya Morita; Keisuke Hirai; Fumio Matsuzuka; Ken-Ichi Kakudoh; Kanji Kuma; Hajime Tamai


Clinical Endocrinology | 1995

A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti‐thyroid drugs

Keisuke Kawai; Hajime Tamai; Sunao Matsubayashi; Toshio Mukuta; Tetsuya Morita; Chiharu Kubo; Kanji Kuma


The Journal of Clinical Endocrinology and Metabolism | 1993

Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).

Hajime Tamai; Toshio Mukuta; Sunao Matsubayashi; Shuji Fukata; Gen Komaki; Kanji Kuma; Lindy F. Kumagai; Shigenobu Nagataki


Clinical Endocrinology | 1994

Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH‐binding inhibitor immunoglobulin

Toshio Mukuta; Hajime Tamai; A. Oshima; Tetsuya Morita; Sunao Matsubayashi; Shuji Fukata; Kanji Kuma


Psychotherapy and Psychosomatics | 1996

Graves’ Disease after the Onset of Panic Disorder

Sunao Matsubayashi; Hajime Tamai; Yoshiaki Matsumoto; Kei-ichi Tamagawa; Toshio Mukuta; Tetsuya Morita; Chiharu Kubo


The Lancet | 1990

Transient postpartum hypothyroidism caused by thyroid-stimulation-blocking antibody

Takeshi Hara; Hajime Tamai; Toshio Mukuta; Shuji Fukata; Kanji Kuma; Masahiro Sugawara

Collaboration


Dive into the Toshio Mukuta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge